Sfoglia per Titolo
Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer
2011-01-01 Lorusso, D; Mainenti, S.; Pietragalla, A.; Fusco, E.; Malaguti, P.; Masciullo, V.; Scambia, G.
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC)
1998-01-01 Preti, P; Poggi, G; Cuomo, Am; Della Cuna, Fsr; Zambelli, A; Pavesi, L
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity
2012-01-01 Ortega, Ms; Esquerdo, G; Cervera Grau, Jm; Barrajon, E; Rodriguez Villalva, S; De Piaggio, M; Peiro, R; De Sanctis, R; Paz Espinoza Venegas, M
Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
2007-01-01 Campagnoli, E; Garassino, I; Santoro, A; De Vincenzo, F; Zucali, Pa; Ceresoli, Gl; Lutman, Fr; Alloisio, M; Soto Parra, Hj; Cavina, R
Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases
2020-01-01 Franzese, Ciro; Comito, Tiziana; Tripoli, Antonella; Franceschini, Davide; Clerici, Elena; Navarria, Pierina; Badalamenti, Marco; D'Agostino, Giuseppe; Loi, Mauro; Mancosu, Pietro; Reggiori, Giacomo; Tomatis, Stefano; Scorsetti, Marta
Phase II trial of hypofractionated VMAT for early stage breast cancer: Acute toxicity and cosmetic results in 840 patients
2016-01-01 De Rose, F; Franceschini, D; Fogliata, A; Iftode, C; Villa, E; Ascolese, Am; Navarria, P; D'Agostino, Gr; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Stravato, A; Scorsetti, M
Phase II trial of hypofractionated VMAT treatment for early stage breast cancer: 2-years outcomes
2016-01-01 De Rose, F; Franceschini, D; Fogliata, A; Iftode, Cs; Villa, E; Ascolese, Am; Navarria, P; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Lobefalo, F; D'Agostino, Gr; Scorsetti, M
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
2016-01-01 De Rose, F; Fogliata, A; Franceschini, D; Navarria, P; Villa, E; Iftode, C; D'Agostino, G; Cozzi, L; Lobefalo, F; Mancosu, P; Tomatis, S; Scorsetti, M
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-years toxicity and clinical results
2016-01-01 Franceschini, D; De Rose, F; Fogliata, A; Iftode, C; Villa, E; Ascolese, Am; Navarria, P; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; D'Agostino, Gr; Scorsetti, M
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM)
2011-01-01 Rea, F.; Favaretto, A. G.; Marulli, G.; Spaggiari, L.; De Pas, T. M.; Ceribelli, A.; Paccagnella, A.; Crivellari, G.; Russo, F.; Ceccarelli, M.; Facciolo, F.
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
2013-01-01 Rea, Federico; Favaretto, Adolfo; Marulli, Giuseppe; Spaggiari, Lorenzo; DePas Tommaso, Martino; Ceribelli, Anna; Paccagnella, Adriano; Crivellari, Gino; Russo, Francesca; Ceccarelli, Matteo; Kazeem, Gbenga; Marchi, Paolo; Facciolo, Francesco
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma
2016-01-01 Belli, C; Piemonti, L; D'Incalci, M; Zucchetti, M; Porcu, L; Cappio, S; Doglioni, C; Allavena, P; Ceraulo, D; Maggiora, P; Dugnani, E; Cangi, Mg; Garassini, G; Reni, M
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases
2019-01-01 Franzese, C; Comito, T; Tozzi, A; De Rose, F; Navarria, P; Mancosu, P; Tomatis, S; Scorsetti, M
Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production
2021-01-01 Franzese, Ciro; Stefanini, Sara; Massaro, Maria; Comito, Tiziana; Navarria, Pierina; Clerici, Elena; Teriaca, Ausilia; Franceschini, Davide; Reggiori, Giacomo; Tomatis, Stefano; Lania, Andrea; Scorsetti, Marta
Phase II Trial on Cisplatin-Adriamycin-Paclitaxel Combination as Neoadjuvant Chemotherapy for Locally Advanced Cervical Adenocarcinoma
2014-01-01 Lorusso, D; Ramondino, S; Mancini, M; Zanaboni, F; Ditto, A; Raspagliesi, F
Phase II trial on SBRT for Liver Metastases: Long-term outcomes and prognostic factors of survival
2017-01-01 Comito, T; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, Gr; Franceschini, D; De Rose, F; Ascolese, A; Di Brina, L; Tomatis, S; Scorsetti, M
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
2018-01-01 Scorsetti, M; Comito, T; Clerici, E; Franzese, C; Tozzi, A; Iftode, C; Di Brina, L; Navarria, P; Mancosu, P; Reggiori, G; Fogliata, A; Tomatis, S; Torzilli, G; Cozzi, L
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract
2019-01-01 Locati, L. D.; Cavalieri, S.; Bergamini, C.; Resteghini, C.; Alfieri, S.; Calareso, G.; Bossi, P.; Perrone, F.; Tamborini, E.; Quattrone, P.; Granata, R.; Galbiati, D.; Platini, F.; Orlandi, E.; Mariani, L.; Licitra, L.
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer
2008-01-01 Guarneri, V; Frassoldati, A; Ficarra, G; Puglisi, F; Andreetta, C; Michelotti, A; Cresti, N; Boni, C; Bisagni, G; Berardi, R; Battelli, N; Santoro, A; Banna, G; Bottini, A; Di Blasio, B; Maiorana, A; Piacentini, F; Giovannelli, S; Jovic, G; Conte, P
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
2003-01-01 Lorusso, D; Ferrandina, G; Greggi, S; Gadducci, A; Pignata, S; Tateo, S; Biamonte, R; Manzione, L; Di Vagno, G; Ferrau, F; Scambia, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phase II Study on Weekly Bolus Topotecan in Advanced or Recurrent Cervical Cancer | 1-gen-2011 | Lorusso, D; Mainenti, S.; Pietragalla, A.; Fusco, E.; Malaguti, P.; Masciullo, V.; Scambia, G. | |
| Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) | 1-gen-1998 | Preti, P; Poggi, G; Cuomo, Am; Della Cuna, Fsr; Zambelli, A; Pavesi, L | |
| Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity | 1-gen-2012 | Ortega, Ms; Esquerdo, G; Cervera Grau, Jm; Barrajon, E; Rodriguez Villalva, S; De Piaggio, M; Peiro, R; De Sanctis, R; Paz Espinoza Venegas, M | |
| Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer | 1-gen-2007 | Campagnoli, E; Garassino, I; Santoro, A; De Vincenzo, F; Zucali, Pa; Ceresoli, Gl; Lutman, Fr; Alloisio, M; Soto Parra, Hj; Cavina, R | |
| Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases | 1-gen-2020 | Franzese, Ciro; Comito, Tiziana; Tripoli, Antonella; Franceschini, Davide; Clerici, Elena; Navarria, Pierina; Badalamenti, Marco; D'Agostino, Giuseppe; Loi, Mauro; Mancosu, Pietro; Reggiori, Giacomo; Tomatis, Stefano; Scorsetti, Marta | |
| Phase II trial of hypofractionated VMAT for early stage breast cancer: Acute toxicity and cosmetic results in 840 patients | 1-gen-2016 | De Rose, F; Franceschini, D; Fogliata, A; Iftode, C; Villa, E; Ascolese, Am; Navarria, P; D'Agostino, Gr; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Stravato, A; Scorsetti, M | |
| Phase II trial of hypofractionated VMAT treatment for early stage breast cancer: 2-years outcomes | 1-gen-2016 | De Rose, F; Franceschini, D; Fogliata, A; Iftode, Cs; Villa, E; Ascolese, Am; Navarria, P; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; Lobefalo, F; D'Agostino, Gr; Scorsetti, M | |
| Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results. | 1-gen-2016 | De Rose, F; Fogliata, A; Franceschini, D; Navarria, P; Villa, E; Iftode, C; D'Agostino, G; Cozzi, L; Lobefalo, F; Mancosu, P; Tomatis, S; Scorsetti, M | |
| Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-years toxicity and clinical results | 1-gen-2016 | Franceschini, D; De Rose, F; Fogliata, A; Iftode, C; Villa, E; Ascolese, Am; Navarria, P; Franzese, C; Comito, T; Tozzi, A; Clerici, E; Liardo, Rle; D'Agostino, Gr; Scorsetti, M | |
| Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM) | 1-gen-2011 | Rea, F.; Favaretto, A. G.; Marulli, G.; Spaggiari, L.; De Pas, T. M.; Ceribelli, A.; Paccagnella, A.; Crivellari, G.; Russo, F.; Ceccarelli, M.; Facciolo, F. | |
| Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma | 1-gen-2013 | Rea, Federico; Favaretto, Adolfo; Marulli, Giuseppe; Spaggiari, Lorenzo; DePas Tommaso, Martino; Ceribelli, Anna; Paccagnella, Adriano; Crivellari, Gino; Russo, Francesca; Ceccarelli, Matteo; Kazeem, Gbenga; Marchi, Paolo; Facciolo, Francesco | |
| Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma | 1-gen-2016 | Belli, C; Piemonti, L; D'Incalci, M; Zucchetti, M; Porcu, L; Cappio, S; Doglioni, C; Allavena, P; Ceraulo, D; Maggiora, P; Dugnani, E; Cangi, Mg; Garassini, G; Reni, M | |
| Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases | 1-gen-2019 | Franzese, C; Comito, T; Tozzi, A; De Rose, F; Navarria, P; Mancosu, P; Tomatis, S; Scorsetti, M | |
| Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production | 1-gen-2021 | Franzese, Ciro; Stefanini, Sara; Massaro, Maria; Comito, Tiziana; Navarria, Pierina; Clerici, Elena; Teriaca, Ausilia; Franceschini, Davide; Reggiori, Giacomo; Tomatis, Stefano; Lania, Andrea; Scorsetti, Marta | |
| Phase II Trial on Cisplatin-Adriamycin-Paclitaxel Combination as Neoadjuvant Chemotherapy for Locally Advanced Cervical Adenocarcinoma | 1-gen-2014 | Lorusso, D; Ramondino, S; Mancini, M; Zanaboni, F; Ditto, A; Raspagliesi, F | |
| Phase II trial on SBRT for Liver Metastases: Long-term outcomes and prognostic factors of survival | 1-gen-2017 | Comito, T; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, Gr; Franceschini, D; De Rose, F; Ascolese, A; Di Brina, L; Tomatis, S; Scorsetti, M | |
| Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up | 1-gen-2018 | Scorsetti, M; Comito, T; Clerici, E; Franzese, C; Tozzi, A; Iftode, C; Di Brina, L; Navarria, P; Mancosu, P; Reggiori, G; Fogliata, A; Tomatis, S; Torzilli, G; Cozzi, L | |
| Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract | 1-gen-2019 | Locati, L. D.; Cavalieri, S.; Bergamini, C.; Resteghini, C.; Alfieri, S.; Calareso, G.; Bossi, P.; Perrone, F.; Tamborini, E.; Quattrone, P.; Granata, R.; Galbiati, D.; Platini, F.; Orlandi, E.; Mariani, L.; Licitra, L. | |
| Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer | 1-gen-2008 | Guarneri, V; Frassoldati, A; Ficarra, G; Puglisi, F; Andreetta, C; Michelotti, A; Cresti, N; Boni, C; Bisagni, G; Berardi, R; Battelli, N; Santoro, A; Banna, G; Bottini, A; Di Blasio, B; Maiorana, A; Piacentini, F; Giovannelli, S; Jovic, G; Conte, P | |
| Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients | 1-gen-2003 | Lorusso, D; Ferrandina, G; Greggi, S; Gadducci, A; Pignata, S; Tateo, S; Biamonte, R; Manzione, L; Di Vagno, G; Ferrau, F; Scambia, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile